Found: 15
Select item for more details and to access through your institution.
Medication Discrepancies and Regimen Complexity in Decompensated Cirrhosis: Implications for Medication Safety.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 12, p. 1207, doi. 10.3390/ph14121207
- By:
- Publication type:
- Article
Development and Evaluation of the Supportive Needs Assessment Tool for Cirrhosis (SNAC).
- Published in:
- Patient Preference & Adherence, 2020, v. 14, p. 599, doi. 10.2147/PPA.S236818
- By:
- Publication type:
- Article
Serum CC-Chemokine Ligand 2 Is Associated with Visceral Adiposity but Not Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
- Published in:
- Digestive Diseases, 2023, v. 41, n. 3, p. 439, doi. 10.1159/000527784
- By:
- Publication type:
- Article
Effectiveness of patient‐oriented education and medication management intervention in people with decompensated cirrhosis.
- Published in:
- Internal Medicine Journal, 2020, v. 50, n. 9, p. 1142, doi. 10.1111/imj.14986
- By:
- Publication type:
- Article
Underappreciation of non‐alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis.
- Published in:
- Internal Medicine Journal, 2018, v. 48, n. 2, p. 144, doi. 10.1111/imj.13667
- By:
- Publication type:
- Article
Optimising care of patients with chronic disease: patient-oriented education may improve disease knowledge and self-management.
- Published in:
- Internal Medicine Journal, 2017, v. 47, n. 8, p. 952, doi. 10.1111/imj.13505
- By:
- Publication type:
- Article
The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease.
- Published in:
- Liver International, 2016, v. 36, n. 3, p. 370, doi. 10.1111/liv.12896
- By:
- Publication type:
- Article
ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity.
- Published in:
- Liver International, 2015, v. 35, n. 6, p. 1673, doi. 10.1111/liv.12760
- By:
- Publication type:
- Article
Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-82315-z
- By:
- Publication type:
- Article
Multiplex Serum Protein Analysis Identifies Novel Biomarkers of Advanced Fibrosis in Patients with Chronic Liver Disease with the Potential to Improve Diagnostic Accuracy of Established Biomarkers.
- Published in:
- PLoS ONE, 2016, v. 11, n. 11, p. 1, doi. 10.1371/journal.pone.0167001
- By:
- Publication type:
- Article
Prevalence of medication discrepancies in patients with cirrhosis: a pilot study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Diagnostic sensitivity of carbohydrate deficient transferrin in heavy drinkers.
- Published in:
- BMC Gastroenterology, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-230X-14-97
- By:
- Publication type:
- Article
Diagnostic sensitivity of carbohydrate deficient transferrin in heavy drinkers.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Patient-oriented education and medication management intervention for people with decompensated cirrhosis: study protocol for a randomized controlled trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Alcohol Consumption in Diabetic Patients with Nonalcoholic Fatty Liver Disease.
- Published in:
- Canadian Journal of Gastroenterology & Hepatology, 2017, p. 1, doi. 10.1155/2017/7927685
- By:
- Publication type:
- Article